Electrolyte disorders induced by six multikinase inhibitors therapy for renal cell carcinoma: a large-scale pharmacovigilance analysis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Electrolyte disorders induced by six multikinase inhibitors therapy for renal cell carcinoma: a large-scale pharmacovigilance analysis ; volume:14 ; number:1 ; day:7 ; month:3 ; year:2024 ; pages:1-12 ; date:12.2024
Scientific reports ; 14, Heft 1 (7.3.2024), 1-12, 12.2024
- Urheber
-
She, Xianhua
Yin, Donghong
Guo, Qian
Tang, Yang
Wang, Shuyun
Wang, Xuyan
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-024-56335-4
- URN
-
urn:nbn:de:101:1-2405102113516.406344172879
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:44 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- She, Xianhua
- Yin, Donghong
- Guo, Qian
- Tang, Yang
- Wang, Shuyun
- Wang, Xuyan
- SpringerLink (Online service)
Ähnliche Objekte (12)
Pharmacovigilance workflow in Europe and Italy and pharmacovigilance terminology
Pharmacovigilance in oncology
Algorithmovigilance, lessons from pharmacovigilance
Hybrid Screen Printable Electrolyte for Large‐Scale Flexible Electrochromic Display Production
Serious adverse events with novel beta-lactam/beta-lactamase inhibitor combinations: a large-scale pharmacovigilance analysis
Renal and electrolyte complications in eating disorders: a comprehensive review
Towards robust pharmacovigilance surveillance systems
An historical overview over Pharmacovigilance
Pharmacoenvironmentology – a component of pharmacovigilance
A Systematic Review of Pharmacovigilance Systems in Developing Countries Using the WHO Pharmacovigilance Indicators
The International Society of Pharmacovigilance (ISoP) Pharmacogenomic Special Interest Group: Pharmacogenomics in Pharmacovigilance
Impact of dietary nitrogen reduction on electrolyte homeostasis in growing goats with a focus on renal electrolyte handling
Pharmacovigilance workflow in Europe and Italy and pharmacovigilance terminology
Pharmacovigilance in oncology
Algorithmovigilance, lessons from pharmacovigilance
Hybrid Screen Printable Electrolyte for Large‐Scale Flexible Electrochromic Display Production
Serious adverse events with novel beta-lactam/beta-lactamase inhibitor combinations: a large-scale pharmacovigilance analysis
Renal and electrolyte complications in eating disorders: a comprehensive review
Towards robust pharmacovigilance surveillance systems
An historical overview over Pharmacovigilance
Pharmacoenvironmentology – a component of pharmacovigilance
A Systematic Review of Pharmacovigilance Systems in Developing Countries Using the WHO Pharmacovigilance Indicators
The International Society of Pharmacovigilance (ISoP) Pharmacogenomic Special Interest Group: Pharmacogenomics in Pharmacovigilance
Impact of dietary nitrogen reduction on electrolyte homeostasis in growing goats with a focus on renal electrolyte handling
Pharmacovigilance workflow in Europe and Italy and pharmacovigilance terminology
Pharmacovigilance in oncology
Algorithmovigilance, lessons from pharmacovigilance
Hybrid Screen Printable Electrolyte for Large‐Scale Flexible Electrochromic Display Production
Serious adverse events with novel beta-lactam/beta-lactamase inhibitor combinations: a large-scale pharmacovigilance analysis
Renal and electrolyte complications in eating disorders: a comprehensive review
Towards robust pharmacovigilance surveillance systems
An historical overview over Pharmacovigilance
Pharmacoenvironmentology – a component of pharmacovigilance
A Systematic Review of Pharmacovigilance Systems in Developing Countries Using the WHO Pharmacovigilance Indicators
The International Society of Pharmacovigilance (ISoP) Pharmacogenomic Special Interest Group: Pharmacogenomics in Pharmacovigilance